Rapport Therapeutics (RAPP) Shares Outstanding (2023 - 2026)

Rapport Therapeutics (RAPP) Shares Outstanding (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Rapport Therapeutics 1.94 Bn 1.94 Bn - 47.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 47.24 Mn
Dec 31, 2025 38.93 Mn
Sep 30, 2025 37.93 Mn
Jun 30, 2025 35.44 Mn
Mar 31, 2025 35.27 Mn
Dec 31, 2024 20.74 Mn
Sep 30, 2024 34.86 Mn
Jun 30, 2024 10.67 Mn
Mar 31, 2024 2.05 Mn
Dec 31, 2023 1.51 Mn
Sep 30, 2023 1.53 Mn
Jun 30, 2023 1.44 Mn